Markets

Commodities

Currencies

Incyte Announces Funding of MINJUVI® for patients with Relapsed or Refractory Follicular Lymphoma through Ontario's FAST Program

Knight Therapeutics Announces Supplemental Regulatory Submission for MINJUVI® in Brazil

Opzelura® Cream Becomes First Steroid-Free Topical JAK Inhibitor Approved in the European Union for Adults with Moderate Atopic Dermatitis

loader